Sofinnova Management VIII’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$38M Hold
1,539,480
20.72% 3
2017
Q3
$39.7M Hold
1,539,480
24.23% 2
2017
Q2
$41.8M Hold
1,539,480
23.4% 1
2017
Q1
$45.9M Sell
1,539,480
-750,000
-33% -$22.4M 24.21% 1
2016
Q4
$62.1M Buy
+2,289,480
New +$62.1M 34.97% 1